Reported value$106K10,000 shares at $10.62
For this personUnusual2 buys · 0 sales on file
Similar buys beat S&P49%117 cases · all buys 46%
Worth a closer look
- Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
- Bought by the CEO, one of the two people with the fullest view of the company.
- About 4× their largest earlier purchase here.
- 4 different insiders bought in the last 90 days.
- Similar past buys beat the S&P 500 49% of the time (117 cases), above the 46% for all buys.
- Their past buys: 3 of 6 beat the S&P 500 over 90 days.
Reasons for caution
- Small next to what they already own (holding up 1.9%).
What happened after this filing
7 days
+1.2%
+1.1% vs S&P
30 days
Pending
due Nov 19
90 days
Pending
due Jan 18
Insider Twins: past buys with the same traits
3+ insiders buying · incl. CEO or CFO · under $250K · stock down 0–20% in 3 months
CEVA Feb 23, 2026 +100.6% vs S&PNRGV Mar 5, 2026 +64.4% vs S&PRDW Mar 20, 2025 +41.1% vs S&PINV Dec 3, 2025 -44.0% vs S&PBWEN Aug 21, 2023 -42.0% vs S&PMKTW Sep 10, 2021 -32.4% vs S&PWhat we couldn't check
- Why they traded. Filings don't say, and we don't guess.
- Company news after the filing, and any private terms.
Summary
Smriti Laxman Popenoe (CEO) bought $106K of DX at about $10.62 on Oct 20, 2026, reported to the SEC on Oct 20, 2026. Buys like this beat the S&P 500 49% of the time since 2020, against 46% for all insider buys. We found 6 points that make it worth a closer look and 1 reason for caution. History, not a prediction.
Following. We'll keep this page updated; see everything you follow. Want an email when the 30 and 90-day results land? Use the DX alerts below.
Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.